Author

Cheng Xiang Foo

The University of QueenslandORCID 0000-0002-7539-7116Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Helle Bielefeldt‐OhmanniD· 2 shared Katharina RonacheriD· 2 shared Daniel Charles ChambersiD· 1 shared Edita RitmejerytėiD· 1 shared Ellesandra C. NoyeiD· 1 shared Georgina McCallumiD· 1 shared Hoang P.L. Uong· 1 shared Julian D. J. SngiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Helle Bielefeldt‐OhmannORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintAug 18, 2026

Targeting the Oxysterol Receptor GPR183 to Mitigate Fibrogenesis in Idiopathic Pulmonary Fibrosis

Minh Dao Ngo, Cheng Xiang Foo, Ziying Hong…·Katharina Ronacher

Targeting GPR183 reduced lung fibrosis and inflammation in a preclinical model, supporting GPR183 as a promising new therapy.

DOI 10.64898/2026.08.09.743811

humanexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintFeb 24, 2026

AVE0991, a Mas receptor agonist, increases influenza and COVID-19 severity in vivo.

Melanie Wu, Julian D. J. Sng, Ellesandra C. Noye…·Kirsty Renfree Short

This study shows that AVE0991, a Mas receptor agonist, reduces cytokines and viral titres in vitro but worsens disease in vivo in viral respiratory infections.

DOI 10.64898/2026.02.23.707600

mouseexperimental assay

𝕏 PostBluesky